Two risk variants in the APOL1 gene on chromosome 22, collectively referred to as APOL1 nephropathy risk alleles are associated with an increased risk of chronic kidney disease, and kidney failure (end-stage kidney disease, ESKD) among self-reported African-American (AA) individuals (1, 2). This evidence concerns the gene APOL1 and chronic kidney disease.